Randomized Proof-of-concept Study of AX-8, a TRPM8 Agonist, in Refractory or Unexplained Chronic Cough

被引：0
|
作者：
Smith, J. [1 ]
Hull, J. [2 ]
Birring, S. S. [3 ]
Morice, A. H. [4 ]
Parker, S. [5 ]
Marsden, P. A. [6 ]
Pavord, I. D. [7 ]
Mcgarvey, L. [8 ]
Fowles, H. [9 ]
Turner, A. [10 ]
Piorot, O. [11 ]
Kitt, M. [12 ]
机构：
[1] Univ Manchester, Div Infect Immun & Resp Med, Manchester, Lancs, England
[2] Royal Brompton Hosp, London, England
[3] Kings Coll Hosp London, Resp Med, London, England
[4] Univ Hull, Resp Res Grp, 1st Floor Daisy Bldg, Cottingham, England
[5] Northumbria Healthcare Trust, North Shields, England
[6] Wythenshawe Hosp, North West Lung Ctr, Manchester, Lancs, England
[7] Univ Oxford, Resp Med Unit, Oxford, England
[8] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland
[9] Nevill Hall Hosp, Abergavenny, England
[10] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England
[11] Axalbion, Div Infect Immun & Resp Med, Lausanne, Switzerland
[12] Axalbion, Mountain View, CA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2532
引用
收藏
页数：1
相关论文
共 38 条
  • [21] Safety and efficacy of cervical 10 kHz cervical spinal cord stimulation (SCS) for the management of refractory chronic migraine: a prospective, proof-of-concept open label study
    Giorgio, Lambru
    Adnan, Al-Kaisy
    Stefano, Palmisani
    Roy, Carganillo
    Samuel, Wesley
    David, Pang
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [22] Novel design of a focal epilepsy proof-of-concept study of RAP-219, a γ-8 transmembrane AMPA receptor protein (TARP) negative allosteric modulator
    Motley, W. W.
    Friedman, D.
    Davis, K. A.
    Galer, B. S.
    Wyant, N.
    Matta, J. A.
    Gammaitoni, A. R.
    Dlugos, D.
    Morrell, M. J.
    French, J. A.
    EPILEPSIA, 2024, 65 : 190 - 190
  • [23] Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of-concept study
    Niesters, M.
    Aarts, L.
    Sarton, E.
    Dahan, A.
    BRITISH JOURNAL OF ANAESTHESIA, 2013, 110 (06) : 1010 - 1016
  • [24] A phase 3, randomized, double-blind, clinical study to evaluate the long-term safety and efficacy of gefapixant in Japanese adult participants with refractory or unexplained chronic cough
    Niimi, Akio
    Sagara, Hironori
    Kikuchi, Masashi
    Arano, Ichiro
    Sato, Asako
    Shirakawa, Masayoshi
    La Rosa, Carmen
    Muccino, David
    ALLERGOLOGY INTERNATIONAL, 2022, 71 (04) : 498 - 504
  • [25] Efficacy and safety of a herbal mixture (Viron® tablets) in the treatment of patients with chronic hepatitis C virus infection: a prospective, randomized, open-label, proof-of-concept study
    Shawkat, Hisham
    Yakoot, Mostafa
    Shawkat, Tarek
    Helmy, Sherine
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 799 - 804
  • [26] Isatoribine, a toll-like receptor 7 agonist, significantly reduced plasma viral load in a clinical proof-of-concept study in patients with chronic hepatitis C virus infection.
    Horsmans, Y
    Berg, T
    Desager, JP
    Muller, T
    Schott, E
    Bauman, L
    Steffy, K
    Fletcher, S
    Banh, V
    Liaw, W
    Kerr, B
    Averett, D
    HEPATOLOGY, 2004, 40 (04) : 282A - 283A
  • [27] Effect of One Week of 8-Hour Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes: A Proof-of-Concept Study
    Mokhlesi, Babak
    Grimaldi, Daniela
    Beccuti, Guglielmo
    Abraham, Varghese
    Whitmore, Harry
    Delebecque, Fanny
    Van Cauter, Eve
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (04) : 516 - 519
  • [28] EFFICACY AND SAFETY OF DUPILUMAB IN PATIENTS WITH SEVERE CHRONIC HAND ECZEMA WITH INADEQUATE RESPONSE OR INTOLERANCE TO ALITRETINOIN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE IIB PROOF-OF-CONCEPT STUDY
    Kamphuis, Esme
    Voorberg, Angelique
    Christ-Offers, Wietske
    Schuttelaar, Marie-Louise A.
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 29 - 29
  • [29] Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study
    Voorberg, Angelique N.
    Kamphuis, Esme
    Christoffers, Wietske A.
    Schuttelaar, Marie L. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (04) : 400 - 409
  • [30] Results from a randomized, double-blind, placebo-controlled, monotherapy trial of IMO-8400 demonstrate clinical proof-of-concept for Toll-like receptor 7, 8, and 9 antagonism in psoriasis
    Balak, D. M. W.
    Doorn, M. B. Avan
    Rissmann, Robert
    Sullivan, Tim
    Burggraaf, Jacobus
    Arbeit, R. D.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB247 - AB247
1234